Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium

International Journal of Systematic and Evolutionary Microbiology
Muriel DerrienWillem M de Vos

Abstract

The diversity of mucin-degrading bacteria in the human intestine was investigated by combining culture and 16S rRNA-dependent approaches. A dominant bacterium, strain MucT, was isolated by dilution to extinction of faeces in anaerobic medium containing gastric mucin as the sole carbon and nitrogen source. A pure culture was obtained using the anaerobic soft agar technique. Strain MucT was a Gram-negative, strictly anaerobic, non-motile, non-spore-forming, oval-shaped bacterium that could grow singly and in pairs. When grown on mucin medium, cells produced a capsule and were found to aggregate. Strain MucT could grow on a limited number of sugars, including N-acetylglucosamine, N-acetylgalactosamine and glucose, but only when a protein source was provided and with a lower growth rate and final density than on mucin. The G + C content of DNA from strain MucT was 47.6 mol%. 16S rRNA gene sequence analysis revealed that the isolate was part of the division Verrucomicrobia. The closest described relative of strain MucT was Verrucomicrobium spinosum (92 % sequence similarity). Remarkably, the 16S rRNA gene sequence of strain MucT showed 99 % similarity to three uncultured colonic bacteria. According to the data obtained in this work,...Continue Reading

References

Nov 1, 1977·Applied and Environmental Microbiology·A A SalyersT D Wilkins
Jan 1, 1976·Antonie van Leeuwenhoek·J T StaleyK Jonge
Jul 1, 1995·Scandinavian Journal of Gastroenterology·J G Ruseler-van EmbdenP Marteau
Jul 1, 1996·Applied and Environmental Microbiology·K H Wilson, R B Blitchington
Dec 1, 1995·Computer Applications in the Biosciences : CABIOS·A A Ptitsyn, D A Grigorovich
Jun 8, 2000·International Journal of Systematic and Evolutionary Microbiology·C M PluggeA J Stams
Apr 26, 2001·International Journal of Systematic and Evolutionary Microbiology·A J LawsonJ Stanley
May 16, 2001·Science·L V Hooper, J I Gordon
Jan 5, 2002·International Journal of Systematic and Evolutionary Microbiology·K J ChinP H Janssen
Oct 2, 2002·Systematic and Applied Microbiology·Rainer SimmeringMichael Blaut
Oct 4, 2002·International Journal of Systematic and Evolutionary Microbiology·Sylvia H DuncanHarry J Flint
Mar 27, 2003·International Journal of Systematic and Evolutionary Microbiology·Erwin G ZoetendalWillem M de Vos
Apr 1, 1993·Applied and Environmental Microbiology·A J StamsC M Plugge
Jan 1, 2002·FEMS Microbiology Ecology·Georgina L HoldHarry J Flint

❮ Previous
Next ❯

Citations

Mar 11, 2011·Inflammatory Bowel Diseases·Nabeetha A NagalingamVincent B Young
Dec 25, 2010·Archives of Microbiology·Daryl B DommanNaomi L Ward
Apr 16, 2005·Current Opinion in Biotechnology·Arthur C OuwehandNina Rautonen
Sep 24, 2009·The British Journal of Nutrition·Kei SonoyamaTetsuji Yanagihara
Oct 6, 2010·The British Journal of Nutrition·Marcel RoberfroidAgnes Meheust
Jun 4, 2010·The ISME Journal·Elizabeth K CostelloRob Knight
Dec 14, 2012·The ISME Journal·Pieter Van den AbbeeleTom Van de Wiele
Mar 23, 2012·The ISME Journal·Clara Belzer, Willem M de Vos
Apr 22, 2011·Nature·Manimozhiyan ArumugamPeer Bork
May 5, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·Francisco GuarnerGraham A W Rook
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
Apr 26, 2013·Briefings in Functional Genomics·Patrice D Cani
May 31, 2013·Glycobiology·Angela MarcobalJustin L Sonnenburg
May 31, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Christophe Chassard, Christophe Lacroix
Aug 25, 2009·Applied and Environmental Microbiology·Kei SonoyamaTatsuya Morita
Dec 18, 2007·Applied and Environmental Microbiology·Muriel DerrienWillem M de Vos
Jan 29, 2008·Applied and Environmental Microbiology·Patricia Ruas-MadiedoAbelardo Margolles
Apr 17, 2012·Applied and Environmental Microbiology·Andrew J CollinsSpencer V Nyholm
Dec 8, 2005·Applied and Environmental Microbiology·Parveen SangwanPeter H Janssen
Mar 24, 2009·Journal of Bacteriology·Hayley ThompsonArthur H F Hosie
Nov 16, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Hannah V CareyRob Knight
Dec 20, 2012·BMC Microbiology·Caroline CayrouMichel Drancourt
Sep 10, 2013·BMC Oral Health·Claes WickströmGunnel Svensäter
Mar 8, 2008·The Journal of General and Applied Microbiology·Eiko TsukinowaMasakazu Goto
Apr 25, 2012·World Journal of Gastroenterology : WJG·Rita J GustafssonCrister Olsson
Feb 28, 2014·Médecine sciences : M/S·Patrice D Cani, Amandine Everard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.